| Product Code: ETC6746866 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Malaria Vaccine Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Malaria Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 China Malaria Vaccine Market - Industry Life Cycle |
3.4 China Malaria Vaccine Market - Porter's Five Forces |
3.5 China Malaria Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Malaria Vaccine Market Revenues & Volume Share, By Agent, 2021 & 2031F |
3.7 China Malaria Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 China Malaria Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Malaria Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government initiatives and funding for malaria control and prevention programs in China. |
4.2.2 Growing awareness about the importance of vaccination and preventive healthcare measures. |
4.2.3 Rise in research and development activities aimed at developing more effective malaria vaccines. |
4.3 Market Restraints |
4.3.1 Limited accessibility and affordability of malaria vaccines in rural and underprivileged regions of China. |
4.3.2 Regulatory challenges and stringent approval processes for new vaccines in the Chinese market. |
5 China Malaria Vaccine Market Trends |
6 China Malaria Vaccine Market, By Types |
6.1 China Malaria Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Malaria Vaccine Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 China Malaria Vaccine Market Revenues & Volume, By Pre-Erythrocytic Vaccine, 2021- 2031F |
6.1.4 China Malaria Vaccine Market Revenues & Volume, By Erythrocytic Vaccine, 2021- 2031F |
6.1.5 China Malaria Vaccine Market Revenues & Volume, By Multi-Antigen Vaccine, 2021- 2031F |
6.2 China Malaria Vaccine Market, By Agent |
6.2.1 Overview and Analysis |
6.2.2 China Malaria Vaccine Market Revenues & Volume, By Plasmodium Falciparum, 2021- 2031F |
6.2.3 China Malaria Vaccine Market Revenues & Volume, By Plasmodium Vivax, 2021- 2031F |
6.2.4 China Malaria Vaccine Market Revenues & Volume, By Anopheles Species, 2021- 2031F |
6.3 China Malaria Vaccine Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 China Malaria Vaccine Market Revenues & Volume, By Intramuscular, 2021- 2031F |
6.3.3 China Malaria Vaccine Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.4 China Malaria Vaccine Market Revenues & Volume, By Intradermal, 2021- 2031F |
6.4 China Malaria Vaccine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 China Malaria Vaccine Market Revenues & Volume, By NGO/Non-Profit Organization, 2021- 2031F |
6.4.3 China Malaria Vaccine Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.4 China Malaria Vaccine Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.5 China Malaria Vaccine Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 China Malaria Vaccine Market Import-Export Trade Statistics |
7.1 China Malaria Vaccine Market Export to Major Countries |
7.2 China Malaria Vaccine Market Imports from Major Countries |
8 China Malaria Vaccine Market Key Performance Indicators |
8.1 Number of individuals vaccinated against malaria in China. |
8.2 Percentage increase in government funding allocated for malaria prevention and vaccination programs. |
8.3 Number of clinical trials conducted for malaria vaccines in China. |
8.4 Increase in public awareness campaigns related to malaria prevention and vaccination. |
8.5 Improvement in vaccine accessibility and distribution in rural areas of China. |
9 China Malaria Vaccine Market - Opportunity Assessment |
9.1 China Malaria Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Malaria Vaccine Market Opportunity Assessment, By Agent, 2021 & 2031F |
9.3 China Malaria Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 China Malaria Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Malaria Vaccine Market - Competitive Landscape |
10.1 China Malaria Vaccine Market Revenue Share, By Companies, 2024 |
10.2 China Malaria Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here